Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.
Saved in:
| Title: | Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma. |
|---|---|
| Authors: | Ito Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Marouf A; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France., Kogure Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan., Koya J; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan., Liévin R; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France., Bruneau J; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Pathology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Tabata M; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Saito Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan., Shingaki S; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan., Yuasa M; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Yamaguchi K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Murakami K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Weil R; Sorbonne Universités, Institut National de la Santé et de la Recherche Médiicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France., Vavasseur M; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France., Andrieu GP; INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Latiri M; INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Veleanu L; INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Dussiot M; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France., André I; Human Lymphohematopoiesis Lab, Université Paris Cité, Imagine Institute, INSERM UMR_S 1163, Paris, France., Joshi A; Human Lymphohematopoiesis Lab, Université Paris Cité, Imagine Institute, INSERM UMR_S 1163, Paris, France., Lagresle-Peyrou C; Biotherapy Clinical Investigation Center, Université Paris Cité, Imagine Institute, INSERM CIC 1416, Assistance Publique-Hopitaux de Paris, Paris, France., Magerus A; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université Paris Cité, Imagine Institute, INSERM UMR_S 1163, Paris, France., Chaubard S; Hematology Department, Limoges University Hospital, Limoges, France., Lavergne D; Hematology Department, Limoges University Hospital, Limoges, France., Bachy E; Hematology Department, Lyon Civils Hospices, Lyon, France.; Lymphoma Immuno-Biology (LIB) Team, Université Claude Bernard Lyon 1, Lyon, France., Brunet E; Laboratory of the Genome Dynamics in the Immune System, Équipe Labéllisée La Ligue Contre Le Cancer, Université Paris Cité, Paris Saclay University, INSERM UMR_S 1163, Imagine Institute, Paris, France., Fataccioli V; Pathology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.; INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France., Brouzes C; INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Laurent C; Department of Pathology, Cancer University Institute of Toulouse Oncopole, Toulouse, France.; Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Toulouse III-Paul-Sabatier University, Toulouse, France., de Leval L; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Traverse-Glehen A; Department of Pathology, Lyon Sud Hospital, Claude Bernard Lyon-1 University, Pierre-Bénite, France., Bossard C; Department of Pathology, Nantes University Hospital, Nantes, France., Parrens M; Department of Pathology, Bordeaux University Hospital, Bordeaux University, Bordeaux, France., Meignin V; Pathology Department, Saint Louis Hospital, Université Paris Cité, Paris, France., Philippe L; Department of Hematology, Annecy Genevois Hospital, Epagny Metz-Tessy, France., Rossignol J; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Suarez F; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Michot JM; Drug Development Department, Gustave Roussy Institute, Paris-Saclay University, Villejuif, France., Tournilhac O; Department of Hematology, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France., Damaj G; Department of Hematology, Caen University Hospital, Normandy University, Caen, France., Lemonnier F; INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France.; Hematology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France., Bôle-Feysot C; Genomics Core Facility, Imagine Institute-SFR Necker, INSERM U1163 and INSERM US24/CNRS UAR3633, Université Paris Cité, Paris, France., Nitschké P; INSERM UMR_S 1163, Bioinformatics Platform, Imagine Institute, Université Paris Cité, Paris, France., Tesson B; Bioinformatics Department, LYSARC, Pierre-Bénite, France., Laurent C; Bioinformatics Department, LYSARC, Pierre-Bénite, France., Molina T; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Pathology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Asnafi V; INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Watatani Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Chiba K; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan., Okada A; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan., Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan., Tsukita S; Advanced Comprehensive Research Organization (ACRO), Teikyo University, Tokyo, Japan., Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Department of Hematology, Toranomon Hospital, Tokyo, Japan., Miyoshi H; Department of Pathology, Kurume University School of Medicine, Kurume, Japan., Ohshima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan., Sakata S; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Dobashi A; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Takeuchi K; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Sanada M; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Gaulard P; Pathology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.; INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France., Jaccard A; Hematology Department, Limoges University Hospital, Limoges, France., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden., Hermine O; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France., Kataoka K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Couronné L; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France. |
| Source: | Cancer research [Cancer Res] 2024 Jul 02; Vol. 84 (13), pp. 2181-2201. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38657099 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ito+Y%22">Ito Y</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Marouf+A%22">Marouf A</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kogure+Y%22">Kogure Y</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Koya+J%22">Koya J</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Liévin+R%22">Liévin R</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bruneau+J%22">Bruneau J</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Pathology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Tabata+M%22">Tabata M</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+Y%22">Saito Y</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shingaki+S%22">Shingaki S</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yuasa+M%22">Yuasa M</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamaguchi+K%22">Yamaguchi K</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Murakami+K%22">Murakami K</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Weil+R%22">Weil R</searchLink>; Sorbonne Universités, Institut National de la Santé et de la Recherche Médiicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vavasseur+M%22">Vavasseur M</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Andrieu+GP%22">Andrieu GP</searchLink>; INSERM UMR&#95;S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Latiri+M%22">Latiri M</searchLink>; INSERM UMR&#95;S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Veleanu+L%22">Veleanu L</searchLink>; INSERM UMR&#95;S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Dussiot+M%22">Dussiot M</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22André+I%22">André I</searchLink>; Human Lymphohematopoiesis Lab, Université Paris Cité, Imagine Institute, INSERM UMR&#95;S 1163, Paris, France.<br /><searchLink fieldCode="AU" term="%22Joshi+A%22">Joshi A</searchLink>; Human Lymphohematopoiesis Lab, Université Paris Cité, Imagine Institute, INSERM UMR&#95;S 1163, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lagresle-Peyrou+C%22">Lagresle-Peyrou C</searchLink>; Biotherapy Clinical Investigation Center, Université Paris Cité, Imagine Institute, INSERM CIC 1416, Assistance Publique-Hopitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Magerus+A%22">Magerus A</searchLink>; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université Paris Cité, Imagine Institute, INSERM UMR&#95;S 1163, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chaubard+S%22">Chaubard S</searchLink>; Hematology Department, Limoges University Hospital, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Lavergne+D%22">Lavergne D</searchLink>; Hematology Department, Limoges University Hospital, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Bachy+E%22">Bachy E</searchLink>; Hematology Department, Lyon Civils Hospices, Lyon, France.; Lymphoma Immuno-Biology (LIB) Team, Université Claude Bernard Lyon 1, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Brunet+E%22">Brunet E</searchLink>; Laboratory of the Genome Dynamics in the Immune System, Équipe Labéllisée La Ligue Contre Le Cancer, Université Paris Cité, Paris Saclay University, INSERM UMR&#95;S 1163, Imagine Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fataccioli+V%22">Fataccioli V</searchLink>; Pathology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.; INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Brouzes+C%22">Brouzes C</searchLink>; INSERM UMR&#95;S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Laurent+C%22">Laurent C</searchLink>; Department of Pathology, Cancer University Institute of Toulouse Oncopole, Toulouse, France.; Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Toulouse III-Paul-Sabatier University, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22de+Leval+L%22">de Leval L</searchLink>; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Traverse-Glehen+A%22">Traverse-Glehen A</searchLink>; Department of Pathology, Lyon Sud Hospital, Claude Bernard Lyon-1 University, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Bossard+C%22">Bossard C</searchLink>; Department of Pathology, Nantes University Hospital, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Parrens+M%22">Parrens M</searchLink>; Department of Pathology, Bordeaux University Hospital, Bordeaux University, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Meignin+V%22">Meignin V</searchLink>; Pathology Department, Saint Louis Hospital, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Philippe+L%22">Philippe L</searchLink>; Department of Hematology, Annecy Genevois Hospital, Epagny Metz-Tessy, France.<br /><searchLink fieldCode="AU" term="%22Rossignol+J%22">Rossignol J</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Suarez+F%22">Suarez F</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Michot+JM%22">Michot JM</searchLink>; Drug Development Department, Gustave Roussy Institute, Paris-Saclay University, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Tournilhac+O%22">Tournilhac O</searchLink>; Department of Hematology, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Damaj+G%22">Damaj G</searchLink>; Department of Hematology, Caen University Hospital, Normandy University, Caen, France.<br /><searchLink fieldCode="AU" term="%22Lemonnier+F%22">Lemonnier F</searchLink>; INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France.; Hematology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.<br /><searchLink fieldCode="AU" term="%22Bôle-Feysot+C%22">Bôle-Feysot C</searchLink>; Genomics Core Facility, Imagine Institute-SFR Necker, INSERM U1163 and INSERM US24/CNRS UAR3633, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nitschké+P%22">Nitschké P</searchLink>; INSERM UMR&#95;S 1163, Bioinformatics Platform, Imagine Institute, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tesson+B%22">Tesson B</searchLink>; Bioinformatics Department, LYSARC, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Laurent+C%22">Laurent C</searchLink>; Bioinformatics Department, LYSARC, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Molina+T%22">Molina T</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Pathology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Asnafi+V%22">Asnafi V</searchLink>; INSERM UMR&#95;S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Watatani+Y%22">Watatani Y</searchLink>; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Chiba+K%22">Chiba K</searchLink>; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Okada+A%22">Okada A</searchLink>; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shiraishi+Y%22">Shiraishi Y</searchLink>; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsukita+S%22">Tsukita S</searchLink>; Advanced Comprehensive Research Organization (ACRO), Teikyo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Izutsu+K%22">Izutsu K</searchLink>; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Department of Hematology, Toranomon Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Miyoshi+H%22">Miyoshi H</searchLink>; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.<br /><searchLink fieldCode="AU" term="%22Ohshima+K%22">Ohshima K</searchLink>; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.<br /><searchLink fieldCode="AU" term="%22Sakata+S%22">Sakata S</searchLink>; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Dobashi+A%22">Dobashi A</searchLink>; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takeuchi+K%22">Takeuchi K</searchLink>; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sanada+M%22">Sanada M</searchLink>; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Gaulard+P%22">Gaulard P</searchLink>; Pathology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.; INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Jaccard+A%22">Jaccard A</searchLink>; Hematology Department, Limoges University Hospital, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Ogawa+S%22">Ogawa S</searchLink>; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Hermine+O%22">Hermine O</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Kataoka+K%22">Kataoka K</searchLink>; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Couronné+L%22">Couronné L</searchLink>; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR&#95;S 1163, Imagine Institute, Université Paris Cité, Paris, France.; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2024 Jul 02; Vol. 84 (13), pp. 2181-2201. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38657099 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.CAN-24-0132 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2181 Titles: – TitleFull: Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ito Y – PersonEntity: Name: NameFull: Marouf A – PersonEntity: Name: NameFull: Kogure Y – PersonEntity: Name: NameFull: Koya J – PersonEntity: Name: NameFull: Liévin R – PersonEntity: Name: NameFull: Bruneau J – PersonEntity: Name: NameFull: Tabata M – PersonEntity: Name: NameFull: Saito Y – PersonEntity: Name: NameFull: Shingaki S – PersonEntity: Name: NameFull: Yuasa M – PersonEntity: Name: NameFull: Yamaguchi K – PersonEntity: Name: NameFull: Murakami K – PersonEntity: Name: NameFull: Weil R – PersonEntity: Name: NameFull: Vavasseur M – PersonEntity: Name: NameFull: Andrieu GP – PersonEntity: Name: NameFull: Latiri M – PersonEntity: Name: NameFull: Veleanu L – PersonEntity: Name: NameFull: Dussiot M – PersonEntity: Name: NameFull: André I – PersonEntity: Name: NameFull: Joshi A – PersonEntity: Name: NameFull: Lagresle-Peyrou C – PersonEntity: Name: NameFull: Magerus A – PersonEntity: Name: NameFull: Chaubard S – PersonEntity: Name: NameFull: Lavergne D – PersonEntity: Name: NameFull: Bachy E – PersonEntity: Name: NameFull: Brunet E – PersonEntity: Name: NameFull: Fataccioli V – PersonEntity: Name: NameFull: Brouzes C – PersonEntity: Name: NameFull: Laurent C – PersonEntity: Name: NameFull: de Leval L – PersonEntity: Name: NameFull: Traverse-Glehen A – PersonEntity: Name: NameFull: Bossard C – PersonEntity: Name: NameFull: Parrens M – PersonEntity: Name: NameFull: Meignin V – PersonEntity: Name: NameFull: Philippe L – PersonEntity: Name: NameFull: Rossignol J – PersonEntity: Name: NameFull: Suarez F – PersonEntity: Name: NameFull: Michot JM – PersonEntity: Name: NameFull: Tournilhac O – PersonEntity: Name: NameFull: Damaj G – PersonEntity: Name: NameFull: Lemonnier F – PersonEntity: Name: NameFull: Bôle-Feysot C – PersonEntity: Name: NameFull: Nitschké P – PersonEntity: Name: NameFull: Tesson B – PersonEntity: Name: NameFull: Laurent C – PersonEntity: Name: NameFull: Molina T – PersonEntity: Name: NameFull: Asnafi V – PersonEntity: Name: NameFull: Watatani Y – PersonEntity: Name: NameFull: Chiba K – PersonEntity: Name: NameFull: Okada A – PersonEntity: Name: NameFull: Shiraishi Y – PersonEntity: Name: NameFull: Tsukita S – PersonEntity: Name: NameFull: Izutsu K – PersonEntity: Name: NameFull: Miyoshi H – PersonEntity: Name: NameFull: Ohshima K – PersonEntity: Name: NameFull: Sakata S – PersonEntity: Name: NameFull: Dobashi A – PersonEntity: Name: NameFull: Takeuchi K – PersonEntity: Name: NameFull: Sanada M – PersonEntity: Name: NameFull: Gaulard P – PersonEntity: Name: NameFull: Jaccard A – PersonEntity: Name: NameFull: Ogawa S – PersonEntity: Name: NameFull: Hermine O – PersonEntity: Name: NameFull: Kataoka K – PersonEntity: Name: NameFull: Couronné L IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 07 Text: 2024 Jul 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1538-7445 Numbering: – Type: volume Value: 84 – Type: issue Value: 13 Titles: – TitleFull: Cancer research Type: main |
| ResultId | 1 |